4LAVINE JK.Vitamin E treatment of nonalcoholic steatohepatitis in ch-ildren:a pilot study[J].Gastroenterology,2002,122:931.
5PIETRO V,CLAUDIA M,ADRIANA F,et al.Vitamin E treatment in pediatric obesity-related liver disease:a randomized study[J].Journal of Pediatric Gastroenterology and Nutrition,2004,38:48.
6SANTOS UN,LANZONI VP,SZEJNFELD J,et al.A randomized double-blind study of the short-time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxycholic acid[J].Braz J M ed Biol Res,2003,36(6):723.
9SATAPATHY SK,GARG S,CHAUHAN R,et al.Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxify-lline on clinical,biochemical,and metabolic parameters of patients with nonalcoholic steatohepatitis[J].Am J Gastroenterol,2004,99:1946.
10ABDELMALEK MF,ANGULO P,JORGENSEN RA,et al.Betain,a promising new agent of patients with nonalcoholic steato-heptitis:results of a pilot study[J].Am J Gastroenterol,2001,96:2711.
1Promrat K, Lutchman G, Uwaifo GI, et al. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology, 2004, 39 (1): 188-196.
2Lowyck I, Fevery J. Statins in hepatobiliary diseases: effects, indications and risks. Acta Gastroenterol Belg, 2007, 70 (4): 381-388.
3Riley P, Sudarshi D, Johal M, et al. Weight loss, dietary advice and statin therapy in non-alcoholic fatty liver disease: a retrospective study. Int J Clin Pract, 2008, 62 (3): 374-381.
4Laurin J, Lindor KD, Crippin JS, et al. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology, 1996, 23 (6): 1464-1467.
5Basaranoglu M, Acbay O, Sonsuz A. A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis. J Hepatol, 1999, 31 (2): 384.
6Cohen DE, Anania FA, Chalasani N; National Lipid Association Statin Safety Task Force Liver Expert Panel. An assessment of statin safety by hepatologists. Am J Cardiol, 2006, 97 (8A): 77C-81C.
7Shirouchi B, Nagao K, Inoue N, et al. Dietary phosphatidylinositol prevents the development of nonalcoholic fatty liver disease in Zucker (fa/fa) rats. J Agric Food Chem, 2008, 56 (7): 2375-2379.
8Kiyici M, Gulten M, Gurel S, et al. Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis. Can J Gastroenterol, 2003, 17 (12): 713- 718.
9Lindor KD, Kowdley KV, Heathcote EJ, et al. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology, 2004, 39 (3): 770-778.
10Kumar S, Sitasawad SL. N-acetylcysteine prevents glucose/glucose oxidase-induced oxidative stress, mitochondrial damage and apoptosis in H9c2 cells. Life Sci, 2009, 84 (11-12): 328-336.
